In the US, Alteplase (alteplase systemic) is a member of the drug class thrombolytics and is used to treat Heart Attack, Ischemic Stroke, IV Catheter Clot and Pulmonary Embolism.
US matches:
- Alteplase
- Alteplase, recombinant Intravenous
- Alteplase, Recombinant
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
B01AD02,S01XA13
CAS registry number (Chemical Abstracts Service)
0105857-23-6
Chemical Formula
C2569-H3894-N746-O781-S40
Molecular Weight
59011
Therapeutic Category
Anticoagulant agent: Fibrinolytic enzyme
Chemical Name
Plasminogen activator (human tissue-type protein moiety), glycoform α
Foreign Names
- Alteplasum (Latin)
- Alteplase (German)
- Alteplase (French)
- Alteplasa (Spanish)
Generic Names
- Alteplase (OS: USAN, BAN)
- rt-PA (IS: USAN)
- t-PA (IS)
- Alteplase (PH: USP 32)
- Alteplase for Injection (PH: USP 32, Ph. Eur. 6, BP 2010)
- Altéplase pour solution injectable (PH: Ph. Eur. 6)
- Alteplase zur Injektion (PH: Ph. Eur. 6)
- Alteplasum ad iniectabile (PH: Ph. Eur. 6)
Brand Names
- Actilyse
Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Austria; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Bulgaria; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Chile; Boehringer Ingelheim, China; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Algeria; Boehringer Ingelheim, Estonia; Boehringer Ingelheim, Spain; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Georgia; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Lithuania; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Latvia; Boehringer Ingelheim, Malta; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, New Zealand; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Peru; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Serbia; Boehringer Ingelheim, Russian Federation; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Tunisia; Boehringer Ingelheim, Turkey; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim, Venezuela; Boehringer Ingelheim, South Africa; German Remedies, India
- Actilyse Cathflo
Boehringer Ingelheim, Germany
- Activacin
Kyowa Hakko Kirin, Japan
- Activase
Genentech, United States; Roche, Canada
- Cathflo
Genentech, United States; Roche, Canada
- Grtpa
Tanabe Mitsubishi, Japan
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.